Correlation Between Sartorius Stedim and Euronext

Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Euronext at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Euronext into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Stedim Biotech and Euronext NV, you can compare the effects of market volatilities on Sartorius Stedim and Euronext and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Euronext. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Euronext.

Diversification Opportunities for Sartorius Stedim and Euronext

0.72

Correlation Coefficient

Sartorius Stedim  Euronext

Poor diversification

The 3 months correlation between Sartorius and Euronext is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Euronext NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Euronext NV and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Euronext. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Euronext NV has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Euronext go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Euronext

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to under-perform the Euronext. In addition to that, Sartorius Stedim is 2.19 times more volatile than Euronext NV. It trades about -0.09 of its total potential returns per unit of risk. Euronext NV is currently generating about 0.25 per unit of volatility. If you would invest  14,300  in Euronext NV on April 16, 2025 and sell it today you would earn a total of  640.00  from holding Euronext NV or generate 4.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sartorius Stedim Biotech  vs.  Euronext NV

Sartorius Stedim Biotech

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Euronext NV

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Euronext NV are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Euronext may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Sartorius Stedim and Euronext

The main advantage of trading using opposite Sartorius Stedim and Euronext positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Euronext can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Euronext will offset losses from the drop in Euronext's long position.

The idea behind Sartorius Stedim Biotech and Euronext NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.